Literature DB >> 26085612

Morphological and Molecular Characterization of Exophiala polymorpha sp. nov. Isolated from Sporotrichoid Lymphocutaneous Lesions in a Patient with Myasthenia Gravis.

Lee K Yong1, Nathan P Wiederhold2, Deanna A Sutton3, Marcelo Sandoval-Denis4, Jonathan R Lindner3, Hongxin Fan3, Carmita Sanders3, Josep Guarro4.   

Abstract

Exophiala species are capable of causing cutaneous and subcutaneous infections in immunocompromised patients. An Exophiala isolate was cultured from a biopsy specimen of a lesion on the forearm of a patient with myasthenia gravis. The patient also had lesions on the palm and distal aspects of the hand, which were successfully treated with a long-term course of itraconazole. A detailed morphological and molecular characterization of the isolate was undertaken. Phylogenetic analysis of the internal transcribed spacer region and portions of the β-tubulin and translation elongation factor 1-alpha genes indicated that the isolate was a novel species closely related to but genetically distinct from species within the Exophiala spinifera clade; the name Exophiala polymorpha sp. nov. is proposed. Morphologically, E. polymorpha most closely resembles E. xenobiotica but it differs in possessing phialides bearing prominent, wide collarettes, and it does not produce chlamydospores.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26085612      PMCID: PMC4540895          DOI: 10.1128/JCM.00622-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

2.  First report of subcutaneous phaeohyphomycosis of the foot caused by Phoma minutella.

Authors:  J G Baker; I F Salkin; P Forgacs; J H Haines; M E Kemna
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

3.  Subcutaneous phaeohyphomycosis due to Exophiala spinifera in an immunocompromised host.

Authors:  Deepa Radhakrishnan; G Jayalakshmi; A Madhumathy; S Thasneem Banu; S Geethalakshmi; G Sumathi
Journal:  Indian J Med Microbiol       Date:  2010 Oct-Dec       Impact factor: 0.985

4.  Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cystic fibrosis. A prospective study.

Authors:  R Horré; K P Schaal; R Siekmeier; B Sterzik; G S de Hoog; N Schnitzler
Journal:  Respiration       Date:  2004 Jul-Aug       Impact factor: 3.580

5.  Infections due to Wangiella dermatitidis in humans: report of the first documented case from the United States and a review of the literature.

Authors:  P E Hohl; H P Holley; E Prevost; L Ajello; A A Padhye
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

6.  Spectrum of clinically relevant Exophiala species in the United States.

Authors:  J S Zeng; D A Sutton; A W Fothergill; M G Rinaldi; M J Harrak; G S de Hoog
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

7.  Subcutaneous phaeohyphomycosis caused by Exophiala xenobiotica in a non-Hodgkin lymphoma patient.

Authors:  Yumi Aoyama; Masayo Nomura; Shinya Yamanaka; Yoko Ogawa; Yasuo Kitajima
Journal:  Med Mycol       Date:  2008-12-19       Impact factor: 4.076

8.  Long-term fungal cultures from sputum of patients with cystic fibrosis.

Authors:  G Haase; H Skopnik; T Groten; G Kusenbach; H G Posselt
Journal:  Mycoses       Date:  1991 Sep-Oct       Impact factor: 4.377

9.  Exacerbation of myasthenia gravis with voriconazole.

Authors:  Raed Azzam; Aasef G Shaikh; Alessandro Serra; Bashar Katirji
Journal:  Muscle Nerve       Date:  2013-05-11       Impact factor: 3.217

10.  A case of Exophiala oligosperma successfully treated with voriconazole.

Authors:  Bassam H Rimawi; Ramzy H Rimawi; Meena Mirdamadi; Lisa L Steed; Richard Marchell; Deanna A Sutton; Elizabeth H Thompson; Nathan P Wiederhold; Jonathan R Lindner; M Sean Boger
Journal:  Med Mycol Case Rep       Date:  2013-09-08
View more
  5 in total

Review 1.  Name Changes for Fungi of Medical Importance, 2012 to 2015.

Authors:  David W Warnock
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

2.  Rapid Identification of Clinically Relevant Members of the Genus Exophiala by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Description of Two Novel Species, Exophiala campbellii and Exophiala lavatrina.

Authors:  Andrew M Borman; Mark Fraser; Adrien Szekely; Daniel E Larcombe; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2017-01-25       Impact factor: 5.948

3.  Species Diversity, Distribution, and Phylogeny of Exophiala with the Addition of Four New Species from Thailand.

Authors:  Tanapol Thitla; Jaturong Kumla; Surapong Khuna; Saisamorn Lumyong; Nakarin Suwannarach
Journal:  J Fungi (Basel)       Date:  2022-07-24

4.  A Novel Exophiala Species Associated With Disseminated Granulomatous Inflammation in a Captive Eastern Hellbender (Cryptobranchus alleganiensis alleganiensis).

Authors:  Cynthia Hopf; Erin A Graham; Connie F C Gibas; Carmita Sanders; James Mele; Hongxin Fan; Michael M Garner; Nathan P Wiederhold; Robert Ossiboff; Noha Abou-Madi
Journal:  Front Vet Sci       Date:  2020-01-31

5.  Exophiala campbellii causing a subcutaneous palmar cyst in an otherwise healthy UK resident.

Authors:  Andrew M Borman; Mark Fraser; William Schilling; Gillian Jones; Robert Pearl; Christopher J Linton; Elizabeth M Johnson
Journal:  Med Mycol Case Rep       Date:  2020-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.